Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |